Multiple Biotech Firms Announce Nasdaq-Compliant Inducement Grants

A group of publicly traded biotechnology and pharmaceutical companies, including ORIC Pharmaceuticals, Intellia Therapeutics, and Insmed, have announced new employee inducement grants. These compensation packages were structured to comply with Nasdaq Listing Rule 5635(c)(4).

4 Sept, 20:30 — 4 Sept, 20:30

Post Share

Sources

Showing 1 of 2 sources

taiwan-newsMostly Factual2h ago

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Taiwan News

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Taiwan News

Read full article →

Coverage Timeline

First report: morningstar · 4 Sept, 20:01|Full coverage: 2 · 29m|Window: 29m

Left-leaningCenterRight-leaning

morningstar4 Sept, 20:01First to report

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Morningstar

taiwan-news4 Sept, 20:30Latest update

Multiple Biotech Firms Announce Nasdaq-Compliant Inducement Grants

Sources

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Taiwan News

Coverage Timeline

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Morningstar

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Taiwan News

Related Stories

Indian Regulator Approves National Stock Exchange’s Record-Breaking IPO

Bloom Energy, Illumina, and Everpure Added to S&P 500 in September Rebalance

Executives at Alector, Babcock, and Sea Limited Sell Company Shares

Canada Loses 42,000 Jobs in August as Summer Hiring Fades